|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/36 | (2006.01) |
| A61P 27/02 | (2018.01) | ||
| A61P 9/00 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 7/02 | (2018.01) | ||
| A61P 11/00 | (2018.01) | ||
| C07K2317/76 | (2013.01) | ||
| C07K2317/92 | (2013.01) | ||
| C07K2317/90 | (2013.01) | ||
| C07K2317/21 | (2013.01) | ||
| A61K2039/505 | (2013.01) | ||
| C07K2317/55 | (2013.01) | ||
| C07K2317/34 | (2013.01) | ||
| C07K 16/36 | (2013.01) |
| (11) | Number of the document | 3325516 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16745341.4 |
| Date of filing the European patent application | 2016-07-21 | |
| (97) | Date of publication of the European application | 2018-05-30 |
| (45) | Date of publication and mention of the grant of the patent | 2021-12-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/043265 |
| Date | 2016-07-21 |
| (87) | Number | WO 2017/015431 |
| Date | 2017-01-26 |
| (30) | Number | Date | Country code |
| 201562194957 P | 2015-07-21 | US | |
| 201562273657 P | 2015-12-31 | US | |
| 201662316310 P | 2016-03-31 | US |
| (72) |
MASON, Shauna , US
KENNISTON, Jon, A. , US
NIXON, Andrew , US
SEXTON, Daniel, J. , US
COMEAU, Stephen, R. , US
ADELMAN, Burt , US
|
| (73) |
Takeda Pharmaceutical Company Limited ,
1-1, Doshomachi 4-chome
Chuo-ku, Osaka-shi, Osaka,
JP
|
| (54) | A MONOCLONAL ANTIBODY INHIBITOR OF FACTOR XIIA |
| A MONOCLONAL ANTIBODY INHIBITOR OF FACTOR XIIA |